Streptozotocin-Induced Diabetic Models in Mice and Rats. (Q53359503)

13 May 2018

title

Streptozotocin-Induced Diabetic Models in Mice and Rats. (English)

1 reference

13 May 2018

author name string

Brian L Furman

series ordinal

1

1 reference

13 May 2018

publication date

1 September 2015

1 reference

13 May 2018

Current protocols in pharmacology

published in

1 reference

13 May 2018

volume

70

1 reference

13 May 2018

page(s)

5.47.1-20

1 reference

13 May 2018

A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Characteristics of learning and memory in streptozocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Studies on Streptozotocin Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

ATP-sensitive potassium channels contribute to the time-dependent alteration in the pentylenetetrazole-induced seizure threshold in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Antidiabetic effect of a new peptide from Squalus mitsukurii liver (S-8300) in streptozocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Diabetogenic action of streptozotocin: relationship of dose to metabolic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Low-dose streptozocin-induced diabetes in mice. Electron microscopy reveals single-cell insulitis before diabetes onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Increased atherosclerosis in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Resistance of the rabbit to streptozotocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Retinal upregulation of inflammatory and proangiogenic markers in a model of neonatal diabetic rats fed on a high-fat-diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Animal models of type 2 diabetes with reduced pancreatic beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Genetic Influence of the Streptozotocin-induced Insulitis and Hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Modeling type 2 diabetes in rats using high fat diet and streptozotocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Effect of pre-germinated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

Diabetic atherosclerosis mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471141755.PH0547S70

10.1002/0471141755.PH0547S70

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018